Advertisement
Commentary| Volume 95, ISSUE 4, P323-325, April 2017

Removing barriers to contraception through use of criteria to assess pregnancy risk

      Safe initiation of many contraceptive methods requires an accurate assessment of whether a woman may already be pregnant. Upon initial thought, routine administration of pregnancy tests would seem to be the easiest way to assess pregnancy status. However, pregnancy tests may not be available in every setting, are associated with some cost and have limitations in detection, particularly for very early or recent pregnancies. The US Centers for Disease Control and Prevention (CDC) developed contraceptive guidance, adapted from that of the World Health Organization, which is intended to provide evidence-based guidance on contraceptive provision and reduce barriers to access and use of contraception. According to the US Selected Practice Recommendations for Contraceptive Use (US SPR), health care providers can evaluate certain criteria related to pregnancy risk before initiating contraception [
      • Curtis K.M.
      • Jatlaoui T.C.
      • Tepper N.K.
      • Zapata L.B.
      • Horton L.G.
      • Jamieson D.J.
      • et al.
      U.S. selected practice recommendations for contraceptive use, 2016.
      ]. These criteria are easy to assess, are likely already administered in routine practice and are highly accurate for excluding pregnancy [
      • Tepper N.K.
      • Marchbanks P.A.
      • Curtis K.M.
      Use of a checklist to rule out pregnancy: a systematic review.
      ]. The US SPR was first issued in 2013 and recently updated in 2016. While no changes were made to the criteria for excluding pregnancy, there may be challenges in interpretation and implementation. The intent of this commentary is to explain the rationale underpinning the current US SPR recommendations [
      • Curtis K.M.
      • Jatlaoui T.C.
      • Tepper N.K.
      • Zapata L.B.
      • Horton L.G.
      • Jamieson D.J.
      • et al.
      U.S. selected practice recommendations for contraceptive use, 2016.
      ] and contribute to the dialog on removing barriers to immediate contraception initiation [
      • Morroni C.
      • Findley M.
      • Westhoff C.
      Does using the “pregnancy checklist” delay safe initiation of contraception?.
      ,
      • Stanback J.
      • Yacobson I.
      • Harber L.
      Proposed clinical guidance for excluding pregnancy prior to contraceptive initiation.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Curtis K.M.
        • Jatlaoui T.C.
        • Tepper N.K.
        • Zapata L.B.
        • Horton L.G.
        • Jamieson D.J.
        • et al.
        U.S. selected practice recommendations for contraceptive use, 2016.
        MMWR Recomm Rep. 2016; 65: 1-66
        • Tepper N.K.
        • Marchbanks P.A.
        • Curtis K.M.
        Use of a checklist to rule out pregnancy: a systematic review.
        Contraception. 2013; 87: 661-665
        • Morroni C.
        • Findley M.
        • Westhoff C.
        Does using the “pregnancy checklist” delay safe initiation of contraception?.
        Contraception. 2017; 95: 331-334
        • Stanback J.
        • Yacobson I.
        • Harber L.
        Proposed clinical guidance for excluding pregnancy prior to contraceptive initiation.
        Contraception. 2017; 95: 326-330
        • Whiteman M.K.
        • Tepper N.K.
        • Kottke M.
        • Curtis K.M.
        • Goedken P.
        • Mandel M.G.
        • et al.
        Using a checklist to assess pregnancy in teenagers and young women.
        Obstet Gynecol. 2014; 123: 777-784
        • Min J.
        • Buckel C.
        • Secura G.M.
        • Peipert J.F.
        • Madden T.
        Performance of a checklist to exclude pregnancy at the time of contraceptive initiation among women with a negative urine pregnancy test.
        Contraception. 2015; 91: 80-84
        • World Health Organization
        Selected practice recommendations for contraceptive use.
        3rd ed. World Health Organization, Geneva2016 ([Available from: http://www.who.int/reproductivehealth/publications/family_planning/SPR-3/en/Accessed February 2, 2017])
        • Cervinski M.A.
        • Gronowski A.M.
        Reproductive-endocrine point-of-care testing: current status and limitations.
        Clin Chem Lab Med. 2010; 48: 935-942
        • Cole L.A.
        Human chorionic gonadotropin tests.
        Expert Rev Mol Diagn. 2009; 9: 721-747
        • Cole L.A.
        The utility of six over-the-counter (home) pregnancy tests.
        Clin Chem Lab Med. 2011; 49: 1317-1322
        • Wilcox A.J.
        • Baird D.D.
        • Dunson D.
        • McChesney R.
        • Weinberg C.R.
        Natural limits of pregnancy testing in relation to the expected menstrual period.
        JAMA. 2001; 286: 1759-1761
        • Association of Reproductive Health Professionals. Initiation of Hormonal Contraceptives
        ([cited 2017 January 30]; Available from:)
        • Reproductive Health Access Project. Quick Start Algorithm
        ([cited 2017 January 30]; Available from:)
        • Lesnewski R.
        • Prine L.
        Initiating hormonal contraception.
        Am Fam Physician. 2006; 74: 105-112
        • Jatlaoui T.C.
        • Curtis K.M.
        Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review.
        Contraception. 2016; 94: 605-611
        • Brahmi D.
        • Steenland M.W.
        • Renner R.M.
        • Gaffield M.E.
        • Curtis K.M.
        Pregnancy outcomes with an IUD in situ: a systematic review.
        Contraception. 2012; 85: 131-139
        • Sanders J.N.
        • Howell L.
        • Saltzman H.M.
        • Schwarz E.B.
        • Thompson I.S.
        • Turok D.K.
        Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
        Am J Obstet Gynecol. 2016; 215: 592.e1-592.e5
        • Turok D.K.
        • Godfrey E.M.
        • Wojdyla D.
        • Dermish A.
        • Torres L.
        • Wu S.C.
        Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
        Hum Reprod. 2013; 28: 2672-2676
        • Santelli J.S.
        • Morrow B.
        • Anderson J.E.
        • Lindberg L.D.
        Contraceptive use and pregnancy risk among U.S. high school students, 1991-2003.
        Perspect Sex Reprod Health. 2006; 38: 106-111